Copyright
        ©The Author(s) 2019.
    
    
        World J Diabetes. Jan 15, 2019; 10(1): 57-62
Published online Jan 15, 2019. doi: 10.4239/wjd.v10.i1.57
Published online Jan 15, 2019. doi: 10.4239/wjd.v10.i1.57
            Table 1 Baseline characteristics
        
    | Entire cohort | Early nutrition | Late nutrition | P value | |
| n | 128 | 67 | 61 | |
| Age, mean (yr) | 47.3 (SD = 17.7) | 45.7 (SD = 18.4) | 49.1 (SD = 16.9) | 0.1970 | 
| Race (n) | ||||
| African American | 25% (32) | 23.9% (16) | 26.2% (16) | 0.1950 | 
| Caucasian | 65% (83) | 67.2% (45) | 62.3% (38) | |
| Other | 10% (13) | 8.9% (7) | 11.5% (7) | |
| Female sex (n) | 50.8% (65) | 37.3% (25) | 62% (38) | 0.0047 | 
| DKA severity | ||||
| Mild | 51 | 33 | 28 | 0.8997 | 
| Moderate | 36 | 19 | 17 | |
| Severe | 31 | 15 | 16 | |
| Mean APACHE IV Mortality | 9.9 (SD = 18.5) | 6.0 (SD = 12.7) | 14.1 (SD = 22.5) | 0.1170 | 
| Mean APACHE IV LOS | 4.6 (SD = 1.8) | 4.2 (SD = 1.5) | 4.8 (SD = 2.0) | 0.8400 | 
            Table 2 Outcomes
        
    | Early nutrition | Late nutrition | P value | |
| Mean time to AG normalization (h) | 11.7 (SD = 15.6) | 20.0 (SD = 40.7) | 0.1642 | 
| Mean time to DKA resolution (h) | 15.4 (SD = 18.8) | 19.6 (SD = 32.6) | 0.1410 | 
| Mortality at 28 d (n) | 2.34% (3) | 0.78 (1) | 0.6300 | 
| Mortality at 90 d (n) | 2.34% (3) | 1.57% (2) | 1.0000 | 
| Hospital LOS (d) | 4.16 (SD = 2.63) | 8.35 (SD = 8.85) | 0.0001 | 
| ICU LOS (d) | 1.38 (SD = 1.17) | 3.12 (SD = 4.58) | 0.0002 | 
| Mean number of complication occurrences: | |||
| Hypoglycemia | 0.97 (SD = 1.49) | 1.54 (SD = 2.47) | 0.1804 | 
| Hypokalemia | 1.18 (SD = 1.4) | 2.21 (SD = 2.1) | 0.0022 | 
| Hyperkalemia | 0.43 (SD = 0.72) | 0.56 (SD = 0.89) | 0.3706 | 
| Hypophosphatemia | 0.73 (SD = 0.9) | 1.67 (SD = 2.4) | 0.0052 | 
| Severe acidosis | 0.04 (SD = 0.21) | 0.20 (SD = 0.73) | 0.1356 | 
- Citation: Lipatov K, Kurian KK, Shaver C, White HD, Ghamande S, Arroliga AC, Surani S. Early vs late oral nutrition in patients with diabetic ketoacidosis admitted to a medical intensive care unit. World J Diabetes 2019; 10(1): 57-62
 - URL: https://www.wjgnet.com/1948-9358/full/v10/i1/57.htm
 - DOI: https://dx.doi.org/10.4239/wjd.v10.i1.57
 
